Retinal detachments

‘Time to theatre’ is crucial in successful retinal detachment treatment

Retinal detachments
Priscilla Lynch
Priscilla Lynch
Published: Thursday, February 1, 2018
Mr Ian Dooley MD
'Time to theatre’ is crucial in successful retinal detachment treatment, according to Mr Ian Dooley MD, Consultant Ophthalmologist and Vitreoretinal Surgeon, Mater Misericordiae University Hospital, Dublin, who gave the European Society of Ophthalmology (SOE) Lecture 2017 on ‘Retinal Detachment – Past, Present and Future’ at the Irish College of Ophthalmologists 2017 Annual Conference in Cavan, Ireland. Retinal detachment develops in approximately one-in-10,000 people per year, and scleral buckle surgery/vitrectomy, cryotherapy and laser (photocoagulation) remain mainstays of treatment, he said. The sooner the patient is treated, the less invasive treatment can be and the better the visual outcome, as patients lose about a line of vision for every three days a retinal detachment remains untreated, Mr Dooley explained. For primary retinal detachments, the reattachment success rate is about 85-to-90%, and in secondary detachments it is about 75%, he said. The key symptoms for retinal detachment are the ‘four Fs’ – floaters, flashes, foggy vision and visual field loss, he explained. Vitreous haemorrhage is relatively common. More than 60% of spontaneous severe vitreous haemorrhage cases would benefit from early vitrectomy, as there may be an underlying retinal tear, detachment or vascular problem – and pain is quite rare.
The earlier patients seek treatment, the less invasive treatment has to be and the higher the success rate
Retinal detachment is more common in older people (often following posterior vitreous detachment complicated by small tears), those who have high myopia, pseudophakes, those with diabetic retinopathy and those with a family history of the condition. It can also be associated with previous cataract surgery and trauma, therefore taking a good patient history is key to correct diagnosis said Mr Dooley. In the past 10 years, there have been noteworthy improvements in treatment (small-gauge surgery, better tamponades, stains and viewing systems) and earlier detection of retinal detachment, Mr Dooley stated. “The earlier patients seek treatment, the less invasive treatment has to be and the higher the success rate, and they are less likely to develop the nastier aspects of retinal detachment, such as proliferative vitreoretinopathy (PVR), re-detachment and permanent loss of vision. It is a very treatable condition and I nearly spend half my time dealing with it, but getting the patient in quickly is the key,” he told EuroTimes. Ian Dooley: donna.kiernan@materprivate.ie
Tags: retina
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...